CC
USNA icon

Centiva Capital’s Usana Health Sciences USNA Stock Holding History

Centiva Capital’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,653
Closed -$295K – 1878
2025
Q2 		$295K Sell
9,653
-1,832
-16% -$52K ﹤0.01% 1195
2025
Q1 		$310K Buy
11,485
+5,151
+81% +$163K 0.01% 1069
2024
Q4 		$227K Buy
6,334
+728
+13% +$27.2K ﹤0.01% 1303
2024
Q3 		$213K Buy
+5,606
New +$230K ﹤0.01% 1789
2024
Q2 		– Sell
-4,144
Closed -$201K – 2521
2024
Q1 		$201K Buy
+4,144
New +$203K ﹤0.01% 1480
2021
Q2 		– Sell
-2,228
Closed -$217K – 1638
2021
Q1 		$217K Buy
+2,228
New +$203K 0.01% 941
2020
Q3 		– Sell
-3,361
Closed -$247K – 888
2020
Q2 		$247K Buy
+3,361
New +$264K 0.01% 454

Other funds holding USNA

SWGC
Summit Wealth Group (Colorado) Colorado Springs, Colorado $1.21B AUM 30.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Centiva Capital's USNA Position: Q3 2025 in Review

Centiva Capital sold out of Usana Health Sciences (USNA) in Q3 2025, closing a stake of 9,653 shares — an estimated $295K sold.

Centiva Capital first reported a position in USNA in Q2 2020 and held it in 7 quarters. The position peaked at $310K in Q1 2025. 165 funds tracked by Wall St. Rank hold USNA as of Q3 2025.

  • Centiva Capital reported no remaining Usana Health Sciences position as of Q3 2025 after selling out during the quarter.
  • Centiva Capital sold 9,653 Usana Health Sciences shares in Q3 2025, an estimated $295K.
  • Centiva Capital first reported a position in Usana Health Sciences in Q2 2020 and held it in 7 quarters.
  • Centiva Capital's Usana Health Sciences position peaked at $310K in Q1 2025.
  • 165 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.